Veltuzumab
Jump to navigation
Jump to search
Veltuzumab | |
---|---|
Term | Veltuzumab |
Short definition | Veltuzumab - (pronounced) (vel-TOO-zoo-mab) substance being studied to treat different types of lymphoma. It attaches to the protein CD20, which is found on B cells (a type of cell in the immune system) and some types of lymphoma cells. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Veltuzumab - (pronounced) (vel-TOO-zoo-mab) substance being studied to treat different types of lymphoma. It attaches to the protein CD20, which is found on B cells (a type of cell in the immune system) and some types of lymphoma cells. This causes the immune system to kill the cancer cells. Veltuzumab is a type of monoclonal antibody. Also called hA20, HCD20 and IMMU-106
External links
- Medical encyclopedia article on Veltuzumab
- Wikipedia's article - Veltuzumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski